Analysts say these Canadian weed stocks could rebound post-legalization
US Senate Majority Leader Schumer’s bill is unlikely to be passed, but it’s a good starting point for negotiations, said
US Senate Majority Leader Schumer’s bill is unlikely to be passed, but it’s a good starting point for negotiations, said
New York-based investment banking company Jefferies Group is initiating coverage of seven U.S. pot stocks — Curaleaf, Green Thumb, Trulieve,
In the last year, cannabis ETFs Purpose and Horizons have returned 157.42% and 136.36% respectively, which is significantly higher than
Wakefield, Massachusetts-based Curaleaf reported record earnings for Q1 this week at US$260 million, up 170% year over year. “These impressive
In what they’re calling the largest American cannabis deal in history, Florida’s Trulieve announced its plans to acquire Arizona-based Harvest
Despite good news like New York legalization and the SAFE banking act advancing, the cannabis capital market haven’t rebounded all
Cannabis stock analyst Jason Spatafora, a.k.a. the Wolf of Weed Street, had harsh predictions for debt-strapped Canadian public companies banking
On this episode – BofC Live features a conversation with Mert Guler of Purves Redmond Ltd. and Stephen Scardello of USI
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.